Zhejiang Orient Gene Biotech Co Ltd
SSE:688298
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Zhejiang Orient Gene Biotech Co Ltd
SSE:688298
|
CN |
|
I
|
Indus Gas Ltd
LSE:INDI
|
GG |
Zhejiang Orient Gene Biotech Co Ltd
Zhejiang Orient Gene Biotech Co., Ltd. engages in the research, development, production and sales of in vitro diagnostic products. The company is headquartered in Huzhou, Zhejiang and currently employs 1,895 full-time employees. The company went IPO on 2020-02-05. The firm's main products are Point of Care Testing (POCT) instant diagnostic reagents, which are mainly used in drug testing, infectious disease testing, eugenic testing, tumor marker testing and cardiac marker testing. The firm also engages in the manufacture and sales of biochemical diagnostic reagents used for dry biochemical diagnostics and biochemical fluid diagnostics. The firm operates its businesses in Mainland China, America, Europe, Asia, Africa and Oceania.
Zhejiang Orient Gene Biotech Co., Ltd. engages in the research, development, production and sales of in vitro diagnostic products. The company is headquartered in Huzhou, Zhejiang and currently employs 1,895 full-time employees. The company went IPO on 2020-02-05. The firm's main products are Point of Care Testing (POCT) instant diagnostic reagents, which are mainly used in drug testing, infectious disease testing, eugenic testing, tumor marker testing and cardiac marker testing. The firm also engages in the manufacture and sales of biochemical diagnostic reagents used for dry biochemical diagnostics and biochemical fluid diagnostics. The firm operates its businesses in Mainland China, America, Europe, Asia, Africa and Oceania.
